DiNuzzo Private Wealth’s West Pharmaceutical WST Stock Holding History

DiNuzzo Private Wealth’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.97K	Hold	8	–	–	﹤0.01%	540
2026 Q2	$2.87K	Buy	8 +1	+14%	+$306	﹤0.01%	554
2026 Q1	$1.76K	Buy	7 +1	+17%	+$249	﹤0.01%	688
2025 Q4	$1.65K	Sell	6 -1	-14%	-$274	﹤0.01%	716
2025 Q3	$1.73K	Buy	7 +5	+250%	+$1.22K	﹤0.01%	689
2025 Q2	$438	Sell	2 -2	-50%	-$428	﹤0.01%	1106
2025 Q1	$896	Sell	4 -3	-43%	-$827	﹤0.01%	865
2024 Q4	$2.29K	Hold	7	–	–	﹤0.01%	549
2024 Q3	$2.1K	Hold	7	–	–	﹤0.01%	597
2024 Q2	$2.31K	Buy	7 +1	+17%	+$353	﹤0.01%	471
2024 Q1	$2.38K	Sell	6 -1	-14%	-$370	﹤0.01%	418
2023 Q4	$2.46K	Buy	+7	New	+$2.48K	﹤0.01%	369

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $343M AUM 13.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Tran Capital Management San Rafael, California $873M AUM 51.28% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

BZWA

Blue Zone Wealth Advisors Los Angeles, California $636M AUM 19.4% 1-Year Est. Return

DiNuzzo Private Wealth's WST Position: Q3 2026 in Review

DiNuzzo Private Wealth held its West Pharmaceutical (WST) position steady in Q3 2026 at 8 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

DiNuzzo Private Wealth first reported a position in WST in Q4 2023 and has held it in 12 quarters since. 115 funds tracked by Wall St. Rank hold WST as of Q3 2026.

DiNuzzo Private Wealth held 8 shares of West Pharmaceutical worth $2.97K as of Q3 2026.
DiNuzzo Private Wealth left its West Pharmaceutical share count unchanged in Q3 2026.
West Pharmaceutical made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #540 holding.
DiNuzzo Private Wealth first reported a position in West Pharmaceutical in Q4 2023 and has held it in 12 quarters since.
115 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.